JP2012532894A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012532894A5 JP2012532894A5 JP2012519850A JP2012519850A JP2012532894A5 JP 2012532894 A5 JP2012532894 A5 JP 2012532894A5 JP 2012519850 A JP2012519850 A JP 2012519850A JP 2012519850 A JP2012519850 A JP 2012519850A JP 2012532894 A5 JP2012532894 A5 JP 2012532894A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- anhydro
- glycero
- galacto
- dideoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 22
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 19
- 229910052739 hydrogen Inorganic materials 0.000 claims 14
- 125000005017 substituted alkenyl group Chemical group 0.000 claims 13
- 125000000547 substituted alkyl group Chemical group 0.000 claims 13
- 239000001257 hydrogen Substances 0.000 claims 12
- 125000003710 aryl alkyl group Chemical group 0.000 claims 11
- 125000002252 acyl group Chemical group 0.000 claims 8
- 150000002431 hydrogen Chemical class 0.000 claims 8
- 125000003342 alkenyl group Chemical group 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 6
- 125000000304 alkynyl group Chemical group 0.000 claims 5
- 150000003852 triazoles Chemical class 0.000 claims 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 241000712431 Influenza A virus Species 0.000 claims 3
- 102000005348 Neuraminidase Human genes 0.000 claims 3
- 108010006232 Neuraminidase Proteins 0.000 claims 3
- 229940124639 Selective inhibitor Drugs 0.000 claims 3
- 230000008030 elimination Effects 0.000 claims 3
- 238000003379 elimination reaction Methods 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- LOTBYPQQWICYBB-UHFFFAOYSA-N methyl n-hexyl-n-[2-(hexylamino)ethyl]carbamate Chemical compound CCCCCCNCCN(C(=O)OC)CCCCCC LOTBYPQQWICYBB-UHFFFAOYSA-N 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 125000006239 protecting group Chemical group 0.000 claims 3
- 125000003107 substituted aryl group Chemical group 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 230000002378 acidificating effect Effects 0.000 claims 2
- 238000003795 desorption Methods 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 150000004820 halides Chemical class 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 229910052698 phosphorus Inorganic materials 0.000 claims 2
- 125000004426 substituted alkynyl group Chemical group 0.000 claims 2
- CCPSTGRFUHTVNN-ZSEVYCOTSA-N (2r,3r,4s)-3-acetamido-4-hydroxy-5-[(e)-3-(4-methylphenyl)prop-2-enyl]-2-[(1r,2r)-1,2,3-trihydroxypropyl]-3,4-dihydro-2h-pyran-6-carboxylic acid Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C(C\C=C\C=2C=CC(C)=CC=2)=C1C(O)=O CCPSTGRFUHTVNN-ZSEVYCOTSA-N 0.000 claims 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims 1
- 101100516563 Caenorhabditis elegans nhr-6 gene Proteins 0.000 claims 1
- -1 R 3 Chemical class 0.000 claims 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 1
- 238000005852 acetolysis reaction Methods 0.000 claims 1
- 125000004423 acyloxy group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims 1
- 238000007068 beta-elimination reaction Methods 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000001143 conditioned effect Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000012039 electrophile Substances 0.000 claims 1
- 150000002118 epoxides Chemical class 0.000 claims 1
- 125000001033 ether group Chemical group 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 229910001385 heavy metal Inorganic materials 0.000 claims 1
- 125000004404 heteroalkyl group Chemical group 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 238000006138 lithiation reaction Methods 0.000 claims 1
- QHIROPCGBMZKSC-XSMZZKNVSA-N methyl (2r,3r,4s)-3-acetamido-4-acetyloxy-5-(3-acetyloxypropyl)-2-[(1s,2r)-1,2,3-triacetyloxypropyl]-3,4-dihydro-2h-pyran-6-carboxylate Chemical compound COC(=O)C1=C(CCCOC(C)=O)[C@H](OC(C)=O)[C@@H](NC(C)=O)[C@H]([C@H](OC(C)=O)[C@@H](COC(C)=O)OC(C)=O)O1 QHIROPCGBMZKSC-XSMZZKNVSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical class OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 150000003536 tetrazoles Chemical class 0.000 claims 1
- 125000003441 thioacyl group Chemical group 0.000 claims 1
- 0 CC1NC(*)=C(*)C(*)(*)C1* Chemical compound CC1NC(*)=C(*)C(*)(*)C1* 0.000 description 5
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2009903329A AU2009903329A0 (en) | 2009-07-16 | Anti-influenza agents | |
| AU2009903329 | 2009-07-16 | ||
| PCT/AU2010/000905 WO2011006208A1 (en) | 2009-07-16 | 2010-07-16 | Anti -influenza agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012532894A JP2012532894A (ja) | 2012-12-20 |
| JP2012532894A5 true JP2012532894A5 (enExample) | 2013-09-05 |
Family
ID=43448806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012519850A Pending JP2012532894A (ja) | 2009-07-16 | 2010-07-16 | 抗インフルエンザ薬 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20120202877A1 (enExample) |
| EP (1) | EP2454248A4 (enExample) |
| JP (1) | JP2012532894A (enExample) |
| CN (1) | CN102612514B (enExample) |
| AU (1) | AU2010273184B2 (enExample) |
| CA (1) | CA2768081A1 (enExample) |
| IL (1) | IL217523A0 (enExample) |
| MX (1) | MX2012000576A (enExample) |
| RU (1) | RU2012105073A (enExample) |
| SG (1) | SG177633A1 (enExample) |
| WO (1) | WO2011006208A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9788539B2 (en) | 2011-05-17 | 2017-10-17 | Velico Medical, Inc. | Platelet protection solution having beta-galactosidase and sialidase inhibitors |
| WO2014055988A1 (en) | 2012-10-05 | 2014-04-10 | Velico Medical, Inc. | Platelet additive solution having a beta-galactosidase inhibitor |
| JP6453050B2 (ja) * | 2013-11-15 | 2019-01-16 | 国立大学法人富山大学 | 2−デオキシ−2,3−ジデヒドロシアル酸誘導体およびその製造法 |
| JP6786095B2 (ja) * | 2016-07-27 | 2020-11-18 | 国立研究開発法人理化学研究所 | シアル酸類縁体 |
| WO2018213933A1 (en) | 2017-05-25 | 2018-11-29 | The Governors Of The University Of Alberta | Methods of preventing or treating atherosclerosis with inhibitors of specific isoenzymes of human neuraminidase |
| CN114423754A (zh) * | 2019-07-30 | 2022-04-29 | 格里菲斯大学 | 抗病毒剂和其用途 |
| US12116382B2 (en) | 2022-11-28 | 2024-10-15 | Hongene Biotech Corporation | Functionalized N-acetylgalactosamine analogs |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP249A (en) * | 1990-04-24 | 1993-03-17 | Biota Scient Management Pty Ltd | Anti-viral compounds. |
| JPH11279168A (ja) * | 1996-07-22 | 1999-10-12 | Sankyo Co Ltd | ノイラミン酸誘導体 |
| US5948816A (en) * | 1996-09-10 | 1999-09-07 | Daikin Industries, Ltd. | 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds |
| AUPR001000A0 (en) * | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| US7045535B2 (en) * | 2001-03-08 | 2006-05-16 | Biocryst Pharmaceuticals, Inc. | Compounds useful for inhibiting paramyxovirus neuraminidase |
-
2010
- 2010-07-16 US US13/384,198 patent/US20120202877A1/en not_active Abandoned
- 2010-07-16 RU RU2012105073/04A patent/RU2012105073A/ru not_active Application Discontinuation
- 2010-07-16 CN CN201080040870.1A patent/CN102612514B/zh not_active Expired - Fee Related
- 2010-07-16 AU AU2010273184A patent/AU2010273184B2/en not_active Ceased
- 2010-07-16 SG SG2012002341A patent/SG177633A1/en unknown
- 2010-07-16 MX MX2012000576A patent/MX2012000576A/es not_active Application Discontinuation
- 2010-07-16 WO PCT/AU2010/000905 patent/WO2011006208A1/en not_active Ceased
- 2010-07-16 EP EP20100799291 patent/EP2454248A4/en not_active Withdrawn
- 2010-07-16 JP JP2012519850A patent/JP2012532894A/ja active Pending
- 2010-07-16 CA CA2768081A patent/CA2768081A1/en not_active Abandoned
-
2012
- 2012-01-12 IL IL217523A patent/IL217523A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012532894A5 (enExample) | ||
| JP2022043078A5 (enExample) | ||
| JP2014500861A5 (enExample) | ||
| JP2012503621A5 (enExample) | ||
| JP2010500343A5 (enExample) | ||
| JP2015531760A5 (enExample) | ||
| JP2012508235A5 (enExample) | ||
| JP2010095546A5 (enExample) | ||
| JP2013518116A5 (enExample) | ||
| JP2015523988A5 (enExample) | ||
| HRP20151061T1 (hr) | Posrednici inhibitora neutralne endopeptidaze i postupak njihove pripreme | |
| JP2005053931A5 (enExample) | ||
| JP2013032389A5 (enExample) | ||
| JP2007302689A5 (enExample) | ||
| JP2009530268A5 (enExample) | ||
| RU2009110413A (ru) | Способ получения производных 3-дигалогенметил-пиразол-4-карбоновой кислоты | |
| JP2013521295A5 (enExample) | ||
| CN105849108A (zh) | 磷脂酰肌醇3-激酶抑制剂的制备方法 | |
| JP2017524742A5 (enExample) | ||
| JP2019214626A5 (enExample) | ||
| JP2019516720A5 (enExample) | ||
| JP2014519507A5 (enExample) | ||
| JP2004529172A5 (enExample) | ||
| JP2015516959A5 (enExample) | ||
| JP2010534246A5 (enExample) |